Study of post-natal effect of chemopreventive agents on ethylnitrosourea-induced transplacental carcinogenesis in rats. III. Inhibitory action of indomethacin, voltaren, theophylline and ε-aminocaproic acid

Carcinogenesis

Volumn 17, Issue 9, 1996, Pages 1935-1939

  Alexandrov, Valerij A ^a   Bespalov, Vladimir G ^a   Petrov, Algerd S ^a   Troyan, Dmitrij N ^a   Lidaks, Margeris Yu ^b  

^a N N PETROV RESEARCH INSTITUTE OF ONCOLOGY   (Russian Federation)

^b LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOCAPROIC ACID; ANTINEOPLASTIC AGENT; DICLOFENAC; ETHYLNITROSOUREA; INDOMETACIN; ORTOPHEN; THEOPHYLLINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN TUMOR; CONTROLLED STUDY; DEATH; DRUG EFFECT; FEMALE; INCIDENCE; KIDNEY TUMOR; MALE; NEWBORN; NONHUMAN; ORAL DRUG ADMINISTRATION; PERIPHERAL NERVE TUMOR; PREGNANCY; PRIORITY JOURNAL; PROGENY; RAT; SPINAL CORD TUMOR; SURVIVAL TIME; TRANSPLACENTAL CARCINOGENESIS;

EID: 0029791557     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.9.1935     Document Type: Article

References (40)

1. Alexandrov, V., Aiello, C. and Rossi, L. (1990) Modifying factors in prenatal carcinogenesis. In Vivo, 4, 327-336.
2. Alexandrov, V.A., Bespalov, V.G., Boone, C.W., Kelloff, G.J. and Malone, W.F. (1991) Study of postnatal effects of chemopreventive agents on offspring of ethylnitrosourea-induced transplacental carcinogenesis in rats. 1. Influence of retinol acetate, α-tocopherol acetate, thiamine chloride, sodium selenite, and α-difluoromethylornithine. Cancer Lett., 60, 177-184.
3. Alexandrov, V.A., Bespalov, V.G., Morozov, V.G., Khavinson, V.Kh. and Anisimov, V.N. (1996) Study of the post-natal effects of chemopreventive agents on ethylnitrosourea-induced transplacental carcinogenesis in rats. II. Influence of low-molecular-weight polypeptide factors from the thymus, pineal gland, bone marrow, anterior hypothalamus, brain cortex and brain white substance. Carcinogenesis, 17, 1931-1934.
4. Ivankovic, S. and Druckrey, H. (1968) Transplacentare Erzeugung maligner Tumoren des Nervensystems. I. Äthyl-nitraso-harnstoff (ANH) an BD IX-Ratten. Z. Krebsforsch., 71, 320-360.
5. Lantos, P.L. and Pilkington, G.J. (1979) The development of experimental brain tumors: a sequential light and electron microscopic study of the subependymal plate. Part 1. Early lesions and abnormal cell clusters. Acta Neuropathol. (Berlin), 45, 167-175.
6. Wattenberg, L.W. (1985) Chemoprevention of cancer. Cancer Res., 45, 1-8.
7. Smith, D.L. and Willis, A.L. (1989) Eicosanoids, their dietary precursors and drugs that modify their production or actions: implications in cancer. In Abraham, S. (ed.), Carcinogenesis and Dietary Fat. Kluwer Academic Publishers, Boston, pp. 53-81.
8. Slaga, T.J. and Digiovanni, J. (1984) Inhibition of chemical carcinogenesis. Chemical Carcinogens. Washington, DC, vol. 2, pp. 1279-1321.
9. Fürstenberger, G., Gross, M. and Marks, F. (1989) Eicosanoids and multistage carcinogenesis in NMRI mouse skin: role of prostaglandins E and F in conversion (first stage of tumor promotion) and progression (second stage of tumor promotion). Carcinogenesis, 10, 91-96.
10. McCormick, D.L., Madigan, M.J. and Moon, R.C. (1985) Modulation of rat mammary carcinogenesis by indomethacin. Cancer Res., 45, 1803-1808;
11. Narisawa, T., Sata, M., Sano, M. and Takahashi, T. (1983) Inhibition of initiation and promotion on N-methylnitrosourea-induced colon carcinogenesis in rats by the non-steroidal anti-inflammatory agent indomethacin. Carcinogenesis, 4, 1225-1227.
12. Pollard, M. and Luckert, P.H. (1980) Indomethacin treatment of rats with dimethylhydrazine-induced intestinal tumor. Cancer Treat. Rev., 64, 1323-1327.
13. Kudo, T., Narisawa, T. and Abo, S. (1980) Antitumor activity of indomethacin on methylazoxymethanol-induced large bowel tumor in rats. Gann, 71, 260-264.
14. Rubio, C.A. (1986) Further studies on the therapeutic effect of indomethacin on esophageal tumor. Cancer, 58, 1029-1031.
15. Bespalov, V.G., Troyan, D.N., Petrov, A.S. and Alexandrov, V.A. (1989) Inhibition of development of esophagus tumors by anti-inflammatory drugs of nonsteroidal and steroidal nature, indomethacin and dexamethasone. Pharmacol. Toxicol., 52, 67-70 (in Russian).
16. Shvarz, G.Ya. and Synbaev, R.D. (1988) Screening and study of new nonsteroidal anti-inflammatory drugs. Pharmacol. Toxicol., 51, 15-21 (in Russian).
17. Reddi, P. and Constandines, S.M. (1972) Tumours: partial suppression by DB-CAMP and theophylline. Nature, 238, 286-287.
18. Nomura, T. (1983) Comparative inhibiting effects of methylxanthines on urethan-induced tumors, malformations, and presumed somatic mutations in mice. Cancer Res., 43, 1342-1346.
19. Zajdela, F. and Latarjet, R. (1978) Ultraviolet light induction of skin carcinoma in the mouse; influence of cAMP modifying agents. Bull. Cancer, 65, 305-314.
20. Corasanti, J.G., Hobika, G.H. and Markus, G. (1982) Interference with dimethylhydrazine induction of colon tumors in mice by ε-aminocaproic acid. Science, 216, 1020-1021.
21. Anisimov, V.N., Iogansen, M.G., Popovic, I.G., Romanov, K.P. and Pliss, G.B. (1988) Spontaneous tumors in rats bred at the N.N.Petrov Research Institute of Oncology of the USSR Ministry of Health. Vopr. Onkol., 34, 704-712 (in Russian).
22. Cerutti, P.A. and Trump, B.F. (1991) Inflammation and oxidative stress in Carcinogenesis. Cancer Cells, 3, 1-7.
23. McCormick, D.L. and Moon, R.C. (1983) Inhibition of mammary Carcinogenesis by flurbiprofen, a nonsteroidal antiinflammatory agent. Br. J. Cancer, 48, 859-861.
24. Rao, C.V., Tokumo, K., Rigotty, J., Zang, E., Kelloff, G. and Reddy, B.S. (1991) Chemoprevention of colon carcinogenesis by dietary administration of piroxicam, α-difluoromethylornithine, 16α-fluoro-5-androsten-17-one, and ellagic acid individually and in combination. Cancer Res., 51, 4528-4534.
25. Kurata, Y., Tsuda, H., Tamano, S. and Ito, N. (1985) Inhibitory potential of acetaminophen and O-m-p-aminophenols for development of α-glutamyltranspeptidase-positive liver cell foci in rats pretreated with dimethylnitrosamine. Cancer Lett., 28, 19-25.
26. Tang, Q., Denda, A., Tsujiuchi, T., Tsutsumi, M., Amanuma, T., Murata, Y., Maruyama, H. and Konishi, Y. (1993) Inhibitory effects of inhibitors of arachidonic acid metabolism on the evolution of rat liver preneoplastic foci into nodules and hepatocellular carcinomas with or without phenobarbital exposure. Jpn. J. Cancer Res., 84, 120-127.
27. Sakata, T., Hasegawa, R., Johansson, S.L., Zenser, T.V. and Cohen, S.M. (1986) Inhibition by aspirin of N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide initiation and sodium saccharin promotion of urinary bladder carcinogenesis in male F344 rats. Cancer Res., 46, 3903-3906.
28. Castonguay, A., Pepin, P. and Stoner, G.D. (1991) Lung tumorigenicity of NNK given orally to A/J mice: its application to chemopreventive efficacy studies. Exp. Lung Res., 17, 485-489.
29. Marnett, L.J. (1992) Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res., 52, 5575-5589.
30. Selby, J.V., Friedman, G.D. and Fireman, B.H. (1989) Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow-up. Cancer Res., 49, 5736-5747.
31. Boothman, D.A., Schlegel, R. and Pardee, A.B. (1988) Anticarcinogenic potential of DNA-repair modulators. Mutat. Res., 202, 393-411.
32. Cho-Chung, Y.S. (1990) Role of cyclic AMP receptor proteins in growth, differentiation and suppression of malignancy: new approaches to therapy. Cancer Res., 50, 7093-7100.
33. El-Bayomy, K. (1994) Evaluation of chemopreventive agents against breast cancer and proposed strategies for future clinical intervention trials. Carcinogenesis, 15, 2395-2420.
34. Perchellet, J.P. and Boutwell, R.K. (1982) Comparison of the effects of 3-isobutyl-1-methylxanthine and adenosine cyclic 3,5-monophosphate on the induction of skin tumors by the initiation-promotion protocol and by the complete carcinogenesis process. Carcinogenesis, 3, 53-60.
35. Theiss, J.C. and Shimkin, M.B. (1978) Inhibition effect of caffeine on spontaneous and urethan-induced lung tumors in strain A mice. Cancer Res., 38, 1757-1761.
36. Petric, J.A., Sandberg, W.A., Cole, M.N., Silberman, M.S. and Collins, D.C. (1985) The inhibitory effect of caffeine on hormone-induced rat breast cancer. Cancer, 56, 1971-1981.
37. Rothwell, K. (1974) Dose-related inhibition of chemical carcinogenesis in mouse skin by caffeine. Nature, 252, 69-70.
38. Kennedy, A.R. (1994) Prevention of carcinogenesis by protease inhibitors. Cancer Res., 54 (Suppl.), 1999-2005.
39. Schmähl, D., Mundt, D. and Schmidt, K.G. (1974) Experimental investigations on the influence upon chemical carcinogenesis. 1st communication. Studies with ethylnitrosourea. Z. Krebsforsch., 82, 91-100.
40. Napalkov, N.P., Rice, J.M., Tomatis, L. and Yamasaki, H. (eds) (1989) Perinatal and Multigeneration Carcinogenesis. IARC Scientific Publication No. 96. IARC, Lyon, France.